These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27650468)

  • 1. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder.
    Bauer MS; Miller CJ; Li M; Bajor LA; Lee A
    Bipolar Disord; 2016 Sep; 18(6):481-489. PubMed ID: 27650468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant action of atypical antipsychotics: focus on ziprasidone monotherapy, with a few twists in the tale.
    Andrade C
    J Clin Psychiatry; 2013 Mar; 74(3):e193-6. PubMed ID: 23561239
    [No Abstract]   [Full Text] [Related]  

  • 3. The Ascendancy of Second-Generation Antipsychotics as Frontline Antimanic Agents.
    Miller CJ; Li M; Penfold RB; Lee AF; Smith EG; Nordberg SS; Osser DN; Bajor L; Zhang F; Bauer MS
    J Clin Psychopharmacol; 2015 Dec; 35(6):645-53. PubMed ID: 26488678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
    Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
    Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic adjunctive therapy to mood stabilizers and 1-year rehospitalization rates in bipolar disorder: A cohort study.
    Hochman E; Krivoy A; Schaffer A; Weizman A; Valevski A
    Bipolar Disord; 2016 Dec; 18(8):684-691. PubMed ID: 27933713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
    Tocco M; Mao Y
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):345-352. PubMed ID: 38639433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithms for bipolar mania.
    Post RM; Denicoff KD; Frye MA; Leverich GS
    Mod Probl Pharmacopsychiatry; 1997; 25():114-45. PubMed ID: 9344373
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
    Müller-Oerlinghausen B; Retzow A; Henn FA; Giedke H; Walden J
    J Clin Psychopharmacol; 2000 Apr; 20(2):195-203. PubMed ID: 10770458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive treatment of acute mania: a clinical overview.
    Sachs GS; Gardner-Schuster EE
    Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
    Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
    BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E; Panicali F; Goetz I; Reed C; Comes M; Tohen M;
    J Affect Disord; 2008 Feb; 106(1-2):63-72. PubMed ID: 17582508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.
    Fenn HH; Robinson D; Luby V; Dangel C; Buxton E; Beattie M; Kraemer H; Yesavage JA
    Am J Psychiatry; 1996 May; 153(5):711-3. PubMed ID: 8615421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Leverich GS; Luckenbaugh DA; Rowe M; Pizzarello S; Kupka RW; Grunze H; Nolen WA
    J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.